• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国青岛城阳区非酒精性脂肪性肝病的生活方式干预

Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China.

作者信息

Sun Wei-Hui, Song Ming-Quan, Jiang Chang-Qing, Xin Yong-Ning, Ma Jian-Lin, Liu Ying-Xun, Ma Lei, Lin Zhong-Hua, Li Chang-Yan, Liu Ling, Zhang Mei, Chu Lei-Lei, Jiang Xiang-Jun, Wan Qiang, Zhou Lin, Ren Rong, Meng Ling-Fang

机构信息

Wei-Hui Sun, Jian-Lin Ma, Ying-Xun Liu, Lei Ma, Qiang Wan, Lin Zhou, Rong Ren, Ling-Fang Meng, Hepatology Department, Qingdao Chengyang People's Hospital, Qingdao 266100, Shandong Province, China.

出版信息

World J Hepatol. 2012 Jul 27;4(7):224-30. doi: 10.4254/wjh.v4.i7.224.

DOI:10.4254/wjh.v4.i7.224
PMID:22855698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3409357/
Abstract

AIM

To evaluate the effect of a 6 and 12 mo lifestyle modification intervention in nonalcoholic fatty liver diseases (NAFLD) in Chengyang District of Qingdao.

METHODS

Participants with NAFLD who had resided in Chengyang District for more than 5 years were enrolled in this study. After the 6 and 12 mo lifestyle modification intervention based on physical activity, nutrition and behavior therapy, parameters such as body weight, body mass index (BMI), waist circumference, serum alanine aminotransferase (ALT), aspartate aminotransferase values, serum cholesterol, triglycerides, fasting glucose, fasting insulin and visceral fat area (VFA), the liver-spleen ratio and the homeostasis model assessment of insulin resistance (HOMA-IR) were evaluated and compared between participants with and without the intervention.

RESULTS

Seven hundred and twenty-four participants were assigned to the lifestyle intervention group (LS) and 363 participants were assigned to the control group (CON). After the intervention, body weights in the LS group were significantly decreased compared to those in the CON group at 6 mo (11.59% ± 4.7% vs 0.4% ± 0.2%, P = 0.001) and at 12 mo (12.73% ± 5.6% vs 0.9% ± 0.3%, P = 0.001). Compared with the CON group, BMI was more decreased in the LS group after 6 and 12 mo (P = 0.043 and P = 0.032). Waist circumference was more reduced in the LS group than in CON (P = 0.031 and P = 0.017). After the 6 and 12 mo intervention, ALT decreased significantly in the LS group (P = 0.003 and P = 0.002). After 6 and 12 mo, the metabolic syndrome rate had decreased more in the LS group compared with the CON group (P = 0.026 and P = 0.017). After 12 mo, the HOMA-IR score decreased more obviously in the LS group (P = 0.041); this result also appeared in the VFA after 12 mo in the LS group (P = 0.035).

CONCLUSION

Lifestyle intervention was effective in improving NAFLD in both 6 and 12 mo interventions. This intervention offered a practical approach for treating a large number of NAFLD patients in the Chengyang District of Qingdao.

摘要

目的

评估在青岛市城阳区对非酒精性脂肪性肝病(NAFLD)患者进行6个月和12个月生活方式改变干预的效果。

方法

纳入在城阳区居住超过5年的NAFLD患者。基于体育活动、营养和行为疗法进行6个月和12个月的生活方式改变干预后,对干预组和非干预组患者的体重、体重指数(BMI)、腰围、血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶值、血清胆固醇、甘油三酯、空腹血糖、空腹胰岛素和内脏脂肪面积(VFA)、肝脾比以及胰岛素抵抗稳态模型评估(HOMA-IR)等参数进行评估和比较。

结果

724名参与者被分配到生活方式干预组(LS),363名参与者被分配到对照组(CON)。干预后,LS组在6个月时(11.59%±4.7% vs 0.4%±0.2%,P = 0.001)和12个月时(12.73%±5.6% vs 0.9%±0.3%,P = 0.001)的体重相较于CON组显著下降。与CON组相比,LS组在6个月和12个月后的BMI下降更明显(P = 0.043和P = 0.032)。LS组的腰围比CON组减少更多(P = 0.031和P = 0.017)。在6个月和12个月干预后,LS组的ALT显著下降(P = 0.003和P = 0.002)。在6个月和12个月后,LS组的代谢综合征发生率相较于CON组下降更多(P = 0.026和P = 0.017)。12个月后,LS组的HOMA-IR评分下降更明显(P = 0.041);12个月后LS组的VFA也出现了同样的结果(P = 0.035)。

结论

生活方式干预在6个月和12个月的干预中对改善NAFLD均有效。该干预为青岛市城阳区大量NAFLD患者提供了一种切实可行的治疗方法。

相似文献

1
Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China.中国青岛城阳区非酒精性脂肪性肝病的生活方式干预
World J Hepatol. 2012 Jul 27;4(7):224-30. doi: 10.4254/wjh.v4.i7.224.
2
[Electroacupuncture combined with lifestyle control on obese nonalcoholic fatty liver disease: a randomized controlled trial].[电针联合生活方式干预对肥胖型非酒精性脂肪性肝病的影响:一项随机对照试验]
Zhongguo Zhen Jiu. 2020 Feb 12;40(2):129-34. doi: 10.13703/j.0255-2930.20190201-k00034.
3
Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.人体测量学指标,包括内脏脂肪和皮下脂肪,对于评估非酒精性脂肪肝高危男童和女童代谢紊乱具有重要意义。
Nutr Clin Pract. 2013 Feb;28(1):101-11. doi: 10.1177/0884533612454884. Epub 2012 Oct 5.
4
Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children.生活方式干预对中国肥胖儿童非酒精性脂肪性肝病的影响。
World J Gastroenterol. 2008 Mar 14;14(10):1598-602. doi: 10.3748/wjg.14.1598.
5
Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease.生活方式的改变可改善非酒精性脂肪性肝病患者的胰岛素抵抗和肝脏组织学。
World J Hepatol. 2012 Jul 27;4(7):209-17. doi: 10.4254/wjh.v4.i7.209.
6
Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.肥胖韩国儿童中胰岛素抵抗与作为非酒精性脂肪性肝病(NAFLD)替代指标的血清丙氨酸氨基转移酶之间的关系。
Diabetes Res Clin Pract. 2008 Sep;81(3):321-6. doi: 10.1016/j.diabres.2008.05.006. Epub 2008 Jun 20.
7
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
8
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.生活方式干预对非肥胖非酒精性脂肪性肝病患者的有益影响。
J Hepatol. 2018 Dec;69(6):1349-1356. doi: 10.1016/j.jhep.2018.08.011. Epub 2018 Aug 22.
9
The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中丙氨酸氨基转移酶活性升高与代谢因素之间的关联。
Metabolism. 2006 Dec;55(12):1604-9. doi: 10.1016/j.metabol.2006.07.021.
10
The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease.胰岛素抵抗在非酒精性脂肪性肝病早期非糖尿病患者中的临床意义。
Ter Arkh. 2018 Aug 27;90(8):63-68. doi: 10.26442/terarkh201890863-68.

引用本文的文献

1
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes.代谢功能障碍相关脂肪性肝病(MASLD):肠道微生物群、胰岛素抵抗和糖尿病之间的相互作用
Front Med (Lausanne). 2025 Aug 14;12:1618275. doi: 10.3389/fmed.2025.1618275. eCollection 2025.
2
Dietary strategies in non-alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review.非酒精性脂肪性肝病患者的饮食策略:从证据到日常临床实践的系统评价。
United European Gastroenterol J. 2023 Sep;11(7):663-689. doi: 10.1002/ueg2.12443. Epub 2023 Jul 25.
3
Nonalcoholic Steatohepatitis, Peroxisome Proliferator-Activated Receptors and Our Good Glitazar: Proof of the Pudding is in the Eating.非酒精性脂肪性肝炎、过氧化物酶体增殖物激活受体与我们优良的格列酮类药物:实践出真知。
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):263-267. doi: 10.1016/j.jceh.2022.01.008. Epub 2022 Jan 25.
4
Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.非酒精性脂肪性肝病患者生活方式的改变:系统评价和荟萃分析。
PLoS One. 2022 Feb 17;17(2):e0263931. doi: 10.1371/journal.pone.0263931. eCollection 2022.
5
Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review.肥胖与非酒精性脂肪性肝病的管理:文献综述。
Semin Liver Dis. 2021 Nov;41(4):435-447. doi: 10.1055/s-0041-1731704. Epub 2021 Jul 9.
6
Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.非酒精性脂肪性肝病的生活方式干预:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jun 11;6(6):CD013156. doi: 10.1002/14651858.CD013156.pub2.
7
Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review.2 型糖尿病中非酒精性脂肪性肝病的管理:生活方式干预的影响,叙述性综述。
Adv Ther. 2020 Apr;37(4):1381-1406. doi: 10.1007/s12325-020-01281-6. Epub 2020 Mar 7.
8
Lifestyle modification in NAFLD/NASH: Facts and figures.非酒精性脂肪性肝病/非酒精性脂肪性肝炎中的生活方式改变:事实与数据。
JHEP Rep. 2019 Nov 5;1(6):468-479. doi: 10.1016/j.jhepr.2019.10.008. eCollection 2019 Dec.
9
Modeling the natural history of fatty liver using lifestyle-related risk factors: Effects of body mass index (BMI) on the life-course of fatty liver.使用与生活方式相关的风险因素对脂肪肝的自然史进行建模:体重指数(BMI)对脂肪肝的终生影响。
PLoS One. 2019 Oct 21;14(10):e0223683. doi: 10.1371/journal.pone.0223683. eCollection 2019.
10
Non-Alcoholic Fatty Liver Disease, an Overview.非酒精性脂肪性肝病概述
Integr Med (Encinitas). 2019 Apr;18(2):42-49.

本文引用的文献

1
DNA methylation and hepatic insulin resistance and steatosis.DNA 甲基化与肝胰岛素抵抗和脂肪变性。
Curr Opin Clin Nutr Metab Care. 2012 Jul;15(4):350-6. doi: 10.1097/MCO.0b013e3283546f9f.
2
Current therapies for nonalcoholic fatty liver disease.非酒精性脂肪性肝病的当前治疗方法。
Drugs Today (Barc). 2011 Dec;47(12):915-22. doi: 10.1358/dot.2011.47.12.1688530.
3
Influence of lifestyle habits, nutritional status and insulin resistance in NAFLD.
Front Biosci (Elite Ed). 2012 Jan 1;4(3):1015-23. doi: 10.2741/E437.
4
Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal.成人和儿童非酒精性脂肪性肝病的治疗:深入探讨治疗方法。
J Gastroenterol. 2012 Jan;47(1):29-36. doi: 10.1007/s00535-011-0467-x. Epub 2011 Oct 8.
5
Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.非酒精性脂肪性肝病(NAFLD)中的营养与身体活动:流行病学证据概述。
World J Gastroenterol. 2011 Aug 7;17(29):3377-89. doi: 10.3748/wjg.v17.i29.3377.
6
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.随机对照试验测试减肥对非酒精性脂肪性肝炎的影响。
Hepatology. 2010 Jan;51(1):121-9. doi: 10.1002/hep.23276.
7
A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff.非酒精性脂肪性肝病患者的体重减轻初步试验,采用家庭为基础的生活方式改变干预措施,由多学科医务人员合作提供。
J Gastroenterol. 2009;44(12):1203-8. doi: 10.1007/s00535-009-0115-x. Epub 2009 Sep 1.
8
Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.肥胖儿童非酒精性脂肪肝病的生活方式干预:2年随访研究。
Arch Dis Child. 2009 Jun;94(6):437-42. doi: 10.1136/adc.2008.143594. Epub 2009 Feb 17.
9
Exercise and the fatty liver.运动与脂肪肝
Appl Physiol Nutr Metab. 2008 Aug;33(4):802-7. doi: 10.1139/H08-059.
10
Prevalence of fatty liver disease and its risk factors in the population of South China.中国南方人群中脂肪肝疾病的患病率及其风险因素
World J Gastroenterol. 2007 Dec 21;13(47):6419-24. doi: 10.3748/wjg.v13.i47.6419.